Trial Details
COMPLETEDBasic Information
| Clinical ID | c454 |
|---|---|
| Identifier | NCT02994836 |
| Trial Title | GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Inflammatory Bowel Disease|Ulcerative Colitis |
| Interventions | BIOLOGICAL: Anti-TNF: Infliximab (Infusion)|DRUG: Anti-TNF discontinuation: Physiological saline solution|BIOLOGICAL: Anti-TNF:Adalimumab (Subcutaneus)|DRUG: Anti-TNF discontinuation: Physiological saline solution |
Participant Information
| Sponsor | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
|---|---|
| City | Madrid |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2017-04-21 |
|---|---|
| Primary Completion Date | 2021-12-31 |
| Completion Date | 2022-12-31 |